Literature DB >> 12550112

A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision.

J E Osborne1, P E Hutchinson.   

Abstract

Recurrence rates following conventional surgery for lentigo maligna (LM) are reported to be between 7% and 15%. However, the studies are few, contain small numbers of patients and have relatively short follow-up. The principle aim of this study was to determine the efficacy of conventional surgery for LM in a large unbiased sample of all LM presenting in a defined geographical area. All LM cases occurring in Leicestershire between 1987 and 1996 were identified. Data were gathered from case notes, general practitioners and the Office for National Statistics (for any mortality data) and patients were invited to attend for examination. There were 89 evaluable patients treated with primary excision, representing the largest reported series to date. There was a false positive rate for diagnostic biopsy for LM (when the correct diagnosis was lentigo maligna melanoma, LMM) of 5% (95% confidence interval, CI: 1% to 14%). The initial excision was histologically incomplete in 9% (4% to 17%) of cases. In completely excised lesions (n=81) the observed recurrence rate was 20% (CI: 12% to 30%) at a mean follow-up of 42 months, which is similar to previous reports. However, Kaplan-Meier analysis yielded an estimated probability of recurrence of 31% (CI: 19% to 50%); time to relapse was up to 66 months. The age and sex of the patient and the site of the lesion were not associated with outcome, but, surprisingly, smaller lesions were associated with incomplete excision and recurrence. Fifteen current lesions were excised with similar success rates: the incomplete re-excision rate was 7% (CI: 0.2% to 32%) and the recurrence rate was 31% (CI: 12% to 83%) at 28 months. The estimated rate of transformation to LMM after initial surgical treatment was 1.5% (CI: 0.3% to 8%), and LMM was not the cause of death in any patient. These recurrence rates following complete primary excision and re-excision following recurrence were high compared with general expectations, which is largely the result of the method of analysis and the long follow-up. The high rate calls into question the accuracy of the routine histological assessment of clearance. The development of LMM was rare following surgery. Copyright 2002 The British Association of Plastic Surgeons. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12550112     DOI: 10.1054/bjps.2002.3967

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  10 in total

1.  Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.

Authors:  Sheila M Valentín-Nogueras; David G Brodland; John A Zitelli; Lorena González-Sepúlveda; Cruz M Nazario
Journal:  Dermatol Surg       Date:  2016-06       Impact factor: 3.398

2.  Reflectance confocal microscopy and dermoscopy aid in evaluating repigmentation within or adjacent to lentigo maligna melanoma surgical scars.

Authors:  C Navarrete-Dechent; M Cordova; K Liopyris; A Rishpon; S Aleissa; A M Rossi; E Lee; C-C J Chen; K J Busam; A A Marghoob; K S Nehal
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-08-23       Impact factor: 6.166

3.  Correlation of Handheld Reflectance Confocal Microscopy With Radial Video Mosaicing for Margin Mapping of Lentigo Maligna and Lentigo Maligna Melanoma.

Authors:  Oriol Yélamos; Miguel Cordova; Nina Blank; Kivanc Kose; Stephen W Dusza; Erica Lee; Milind Rajadhyaksha; Kishwer S Nehal; Anthony M Rossi
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

4.  Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice.

Authors:  Joshua B Wilson; Hobart W Walling; Richard K Scupham; Andrew K Bean; Roger I Ceilley; Kirsten E Goetz
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

5.  Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series.

Authors:  Daniel Garcia; Robert E Eilers; S Brian Jiang
Journal:  J Clin Investig Dermatol       Date:  2017-02-27

Review 6.  Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment.

Authors:  Hildur Helgadottir; Iara Rocha Trocoli Drakensjö; Ada Girnita
Journal:  Front Oncol       Date:  2018-06-12       Impact factor: 6.244

7.  Evaluating the Diagnostic Accuracy of Reflectance Confocal Microscopy to Diagnose Skin Cancer: Protocol for a Prospective, Multicenter Study.

Authors:  Naomi D Herz; Anastasia Chalkidou; Fiona Reid; Stephen F Keevil; Andrew Coleman; Emma Craythorne; Rakesh Patalay
Journal:  JMIR Res Protoc       Date:  2018-08-09

Review 8.  Current perspectives on Mohs micrographic surgery for melanoma.

Authors:  Derek Beaulieu; Ramin Fathi; Divya Srivastava; Rajiv I Nijhawan
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-06-20

9.  Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma.

Authors:  Iara R T Drakensjö; Einar Rosen; Margareta Frohm Nilsson; Ada Girnita
Journal:  Acta Derm Venereol       Date:  2020-10-06       Impact factor: 3.875

10.  Linguine technique for excision of lentigo maligna and poorly defined non-melanotic skin cancer - A case series.

Authors:  Joseph Ward; Grammatiki Mitsala; Marios Petsios; Antonio Orlando
Journal:  JPRAS Open       Date:  2019-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.